Quarterly report pursuant to Section 13 or 15(d)

Commitments and contingencies (Details Narrative)

v3.23.1
Commitments and contingencies (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Aug. 27, 2021
Mar. 31, 2023
Jun. 30, 2020
Dec. 31, 2022
Dec. 31, 2021
Oct. 31, 2022
Sep. 30, 2022
Aug. 31, 2022
Law suit filing date   May 28, 2019            
Settlement Agreement and Mutual Release [Member] | G Farma Settlors [Member]                
Liability for Unpaid Claims and Claims Adjustment Expense Schedule, Discussion The Settlement Agreement requires the G Farma Settlors to pay the Company an aggregate of $500,000 plus interest, payable monthly as follows: (i) $500 per month for 12 months beginning on September 5, 2021, (ii) $1,000 per month for 12 months beginning September 5, 2022, (iii) $2,000 per month for 12 months beginning September 5, 2023, and (iv) increasing by an additional $1,000 per month on each succeeding September 5th thereafter, until the settlement amount and accrued unpaid interest is paid in full. Interest on the unpaid balance shall initially accrue at the rate of 4.25%, commencing February 25, 2021, and shall be adjusted on February 25th of each year to equal the Prime Rate as published in the Wall Street Journal plus 1%              
Liability for unpaid claims and claims adjustment expense, net $ 500,000         $ 500,000 $ 500,000 $ 500,000
Liability for unpaid claims $ 2,000,000         2,000,000 2,000,000 2,000,000
Liability for accrued unpaid interest           $ 2,000,000 $ 2,000,000 $ 2,000,000
G FarmaLabs Limited [Member]                
Sale leaseback transaction, net book value     $ 622,670          
Loss contingency receivable, proceeds     $ 249,481          
Other income   $ 0   $ 3,550 $ 2,000